M. Zhao

ORCID: 0000-0003-3127-0604
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometriosis Research and Treatment
  • Reproductive System and Pregnancy
  • Pregnancy and Medication Impact
  • Endometrial and Cervical Cancer Treatments
  • ATP Synthase and ATPases Research
  • Endoplasmic Reticulum Stress and Disease
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation
  • Estrogen and related hormone effects
  • Viral-associated cancers and disorders
  • Heat shock proteins research
  • Circular RNAs in diseases

Nanjing Medical University
2010-2023

Suzhou Municipal Hospital
2023

Nanjing Maternity and Child Health Care Hospital
2010-2011

Obstetrics and Gynecology Hospital of Fudan University
2004-2010

Ovarian cancer is the major gynaecologic malignancy and leading cause of death in gynaecological cancer. Heat shock proteins (HSPs) are highly expressed many malignant cancers involved metastasis including ovarian The early detection peritoneal metastases epithelial may be more important clinical care. HSP27, a small heat protein, correlated with tissues. In this study, we investigated whether levels total HSP27 were detectable serum it could predictive biomarker for Serum samples from 48...

10.1007/s13277-013-1139-7 article EN Tumor Biology 2013-09-04

Multidrug resistance severely limits the efficacy of ovarian cancer (OC) treatment. Recent studies have revealed carcinogenic role LINC00707 RNA. However, in development multidrug OC has not been clarified. Therefore, aim this study was to investigate relationship between and OC, which can facilitate new therapeutic agents for effectively addressing issue. The RNA expression LINC00707, miR-382-5p leucine-rich repeat kinase 2 (LRRK2) SKOV3 (a human cell line) cells detected by qRT-PCR....

10.18388/abp.2020_6503 article EN cc-by Acta Biochimica Polonica 2023-10-03

10.1136/ijgc-00009577-200409001-00454 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2004-09-01
Coming Soon ...